chr6-143942165-C-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001317162.2(PLAGL1):ā€‹c.651G>Cā€‹(p.Gln217His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000979 in 1,614,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000046 ( 0 hom., cov: 32)
Exomes š‘“: 0.00010 ( 0 hom. )

Consequence

PLAGL1
NM_001317162.2 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.76
Variant links:
Genes affected
PLAGL1 (HGNC:9046): (PLAG1 like zinc finger 1) This gene encodes a C2H2 zinc finger protein that functions as a suppressor of cell growth. This gene is often deleted or methylated and silenced in cancer cells. In addition, overexpression of this gene during fetal development is thought to be the causal factor for transient neonatal diabetes mellitus (TNDM). Alternative splicing and the use of alternative promoters results in multiple transcript variants encoding two different protein isoforms. The P1 downstream promoter of this gene is imprinted, with preferential expression from the paternal allele in many tissues. [provided by RefSeq, Nov 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.13136637).
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PLAGL1NM_001317162.2 linkuse as main transcriptc.651G>C p.Gln217His missense_variant 8/8 ENST00000674357.1 NP_001304091.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PLAGL1ENST00000674357.1 linkuse as main transcriptc.651G>C p.Gln217His missense_variant 8/8 NM_001317162.2 ENSP00000501459 P1Q9UM63-1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152188
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000199
AC:
5
AN:
251464
Hom.:
0
AF XY:
0.0000221
AC XY:
3
AN XY:
135912
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000440
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000103
AC:
151
AN:
1461892
Hom.:
0
Cov.:
32
AF XY:
0.0000976
AC XY:
71
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000122
Gnomad4 OTH exome
AF:
0.000248
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152188
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74354
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000103
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000113
Hom.:
0
Bravo
AF:
0.0000416
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.000273
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 28, 2022The c.651G>C (p.Q217H) alteration is located in exon 7 (coding exon 2) of the PLAGL1 gene. This alteration results from a G to C substitution at nucleotide position 651, causing the glutamine (Q) at amino acid position 217 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.26
T;T;.;T;T;.;T;T;.;T;T;.;T;.
Eigen
Benign
-0.041
Eigen_PC
Benign
-0.0047
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.74
.;.;T;.;.;T;T;.;.;.;.;.;.;.
M_CAP
Benign
0.0081
T
MetaRNN
Benign
0.13
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.9
L;L;.;L;L;.;L;L;.;L;L;.;L;.
MutationTaster
Benign
0.64
D;D;D;D;D;D;D;N;N;N
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-2.1
N;.;.;N;N;N;N;.;N;.;.;.;N;N
REVEL
Benign
0.028
Sift
Pathogenic
0.0
D;.;.;D;D;D;D;.;D;.;.;.;D;D
Sift4G
Uncertain
0.0070
D;.;T;D;D;D;D;.;D;D;.;.;D;D
Polyphen
0.52
P;P;.;P;P;.;P;P;.;P;P;.;P;.
Vest4
0.39
MutPred
0.33
Loss of ubiquitination at K213 (P = 0.1083);Loss of ubiquitination at K213 (P = 0.1083);.;Loss of ubiquitination at K213 (P = 0.1083);Loss of ubiquitination at K213 (P = 0.1083);.;Loss of ubiquitination at K213 (P = 0.1083);Loss of ubiquitination at K213 (P = 0.1083);.;Loss of ubiquitination at K213 (P = 0.1083);Loss of ubiquitination at K213 (P = 0.1083);.;Loss of ubiquitination at K213 (P = 0.1083);.;
MVP
0.39
MPC
0.81
ClinPred
0.28
T
GERP RS
3.7
Varity_R
0.19
gMVP
0.38

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs375679973; hg19: chr6-144263302; API